Drug
Topical Endoxifen
Topical Endoxifen: highest development phase Phase 2, developed by Atossa Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Atossa Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Topical endoxifen NCT04616430 | Phase 2 | Mammographic Breast Density |
Latest
No recent events.
Follow Topical Endoxifen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.